We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.30 | 0.83% | 36.60 | 36.30 | 37.40 | 36.65 | 36.10 | 36.10 | 549,476 | 16:35:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 214.41 | 196.88M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/6/2018 10:59 | Both day and year chart are now in the shape of the Loch Ness Monster. As technical a description as you'll ever find! It looks good to me! | silverfern | |
19/6/2018 10:08 | I am thinking that there is a lot of hair in Asia | malcolmmm | |
19/6/2018 10:00 | 101.62 to buy 99.92p to sell at the moment so as we thought ,the price is recovering as this profit enhancing deal is digested | malcolmmm | |
19/6/2018 09:09 | Silverfern, alas you’re right. I dialed in to the call, registered for questions, of course didn’t get a chance. Anyway, the deal does sound to be good. I like that they concentrate on what I call essential products that have a necessity to them. Finances probably maxed out until cashflow reigns the leverage in. Questions asked: - drop in Chinese sales in 2017 due to change in distributior - prior dist. stocked up before end of agreement so had loads of stock to sell - whether they would do more deals - yes continually looking but will wait to 2.5 leverage comes down - capacity to take on this deal - should be ok as mainly run from Paris office so less impact on day to day running In conclusion I feel it’s a good deal, market seems to agree given the share price reaction. Let’s see how it goes. Would like to see that debt coming off quickly though... | cisk | |
19/6/2018 08:43 | Cisk, we've all seen it before. I wonder what the pressure from the other side would be- it will be far more costly to offer to PIs, and take six weeks instead of one day, and oh here's a letter from Blackrock complaining about the company freezing out iis that have supported Alliance over the years. NOt saying I agree with it, mind. | silverfern | |
19/6/2018 08:29 | Paying £60m for £7.1m EBITDA (ratio of 8.5) seems like a good deal to me. As a whole Alliance Pharma trades on a price to EBITDA of around 17, or just under 20 if you include the debt. So a nicely earnings enhancing deal. | madmix | |
19/6/2018 08:28 | Regardless of the deal, not happy about the way we’ve been shut out from fundraising. | cisk | |
19/6/2018 08:26 | Picked some up on the dip first thing. | 5chipper | |
19/6/2018 08:25 | Looks good to me, adds to the growing number of new products and profit stream. | malcolmmm | |
19/6/2018 08:24 | I dont think nine times net earnings is pricey. And they buy products that from companies that are either too small or too large to prioritise marketing and sell thru. So I would expect those earnings to increase from Day 1. | silverfern | |
19/6/2018 08:14 | I have bought a few more but had to pay almost 98p. | martinthebrave | |
19/6/2018 07:59 | Looks a very pricey deal to me, apart from being one where private shareholders are sidelined. Ballooning debt makes me uneasy, but who knows. At least Brexit proof. | dozey3 | |
19/6/2018 07:44 | Might go down to the placing price of 91p. If so I'll pick up another tranche as they won't stay there long | volsung | |
19/6/2018 07:43 | As the market is bearish right now is easily spooked i expect an opening price of 91p which I'll take as a buying opportunity. | silverfern | |
19/6/2018 07:39 | Placing & Acquisition. Acquiring exclusive marketing rights to Nizoral, a medical, anti-dandruff shampoo brand, for £60m. Materially earnings enhancing in Y1. 91p Placing (99p close) is a bit low but the share price has risen a lot recently. Should be Ok. | martinthebrave | |
19/6/2018 07:24 | Alliance Pharma PLC Nizoral Acquisition in APAC. I'm wondering what this means for the share price | mshafiq | |
14/6/2018 14:21 | Looks like we got the div payment thrown in for nothing , when you have a lot of them its not insignificant | malcolmmm | |
12/6/2018 17:16 | Nope It was me topping up my ISA | marksp2011 | |
12/6/2018 16:56 | Looks likely that the Diclectin authorisation news come out to late for SCSW to add to their portfolio this month. they recommended APH as a buy at 83p on the 9th June after meeting the management. But some big buys in the last five days looks like institutional buying on the dramatically enhanced prospects here. | malcolmmm | |
12/6/2018 14:58 | 100p now to sell | volsung | |
12/6/2018 14:53 | Someone just paid 100p. I think they'll make money on it too! | silverfern | |
12/6/2018 13:59 | Just a whisker away from one of your British pounds. Who'd a thunk it? | volsung | |
12/6/2018 12:14 | The best laid plans of mice and men eh! Let's hope so as even a rumour with hive it a lift probably. | jpuff |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions